CELL COMMUN SIGNAL 润色咨询

Cell Communication and Signaling

出版年份:2003 年文章数:855 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:1.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2024-09-21 FFFFFFFish 来自辽宁省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:线粒体
    经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。

    18

    展开18条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2024-12-07 ms5000001996918480

    偏重的研究方向:信号通路;分子机制;心血管
    经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。

    10

    展开10条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2025-01-22 mmxgg091801052023 来自江苏省

    大家都大修回去多久有消息的,天天很焦急的看系统...

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2018-01-31 1de6cd52m45(暂无匿称)

    审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2025-01-08 ms3000002056268783 来自安徽省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2024-12-17 mmxgg091801052023 来自江苏省

    有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2024-12-04 148893c2m57(暂无昵称) 来自重庆

    偏重的研究方向:肿瘤
    经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2024-11-29 dujiang 来自河南省

    11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2024-11-27 ms3000000983513178 来自湖北省

    最近,是不是慢了?技术审查5天了,还没结束!

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2226930, encodeId=258d222693080, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:线粒体<br>经验分享:机制综述,投稿到接收3个月,中间还包括返修1个月。感觉看编辑喜不喜欢,处理速度会非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a45609958, createdName=FFFFFFFish, createdTime=Sat Sep 21 21:04:02 CST 2024, time=2024-09-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2241241, encodeId=921a224124137, content=偏重的研究方向:信号通路;分子机制;心血管<br>经验分享:24.07.07 Submitted 24.07.08 Submission checks complete 24.07.08 Editor assigned 24.07.16 Reviewers invited 24.07.16 Reviews agreed 24.07.17 Reviews agreed 24.07.22 Reviews received 24.07.24 Reviews agreed 24.07.25 Reviews received 24.08.01 Reviews received 24.08.30 Revision requested 24.09.15 Submitted 24.09.16 Submission checks complete 24.11.21 Reviewers invited 24.11.21 Reviews agreed 24.11.21 Reviews agreed 24.11.21 Reviews received 24.11.27 Reviews agreed 24.11.29 Reviews received 24.12.03 Revision requested 24.12.03 Submitted 24.12.05 Submission checks complete 24.12.06 Accepted Cell Communication and Signaling投稿分享: 1.审稿速度非常快,一审半个月,之后编辑迟迟没有返回审稿意见,催了下编辑助理,一周后返回审稿意见。 2.修改时间非常短,只有两周,因为有大量内容需要修改,所以延迟了两天返回。 3.修回后一个月,迟迟没有送审。发邮件给编辑助理,编辑助理说已成功通知编辑,但是又过了一个月,并没有任何的消息。最后通过网上寻找编辑的个人邮箱发送邮件咨询,第二天再次送审。 4.虽然一审三个审稿人都接受了审稿,但是有一个人迟迟没有返回审稿意见,编辑直接决定小修,然后小修完当天返回,通过技术审查后第二天顺利接收,整体历时五个月,速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Sat Dec 07 15:13:17 CST 2024, time=2024-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2249195, encodeId=fb252249195ac, content=大家都大修回去多久有消息的,天天很焦急的看系统..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Wed Jan 22 12:26:56 CST 2025, time=2025-01-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=552210, encodeId=8a4555221094, content=审稿挺快的1个多月,大修,每个问题都认真回答,并补充数据后,很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afee1695969, createdName=1de6cd52m45(暂无匿称), createdTime=Wed Jan 31 14:52:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247068, encodeId=4e12224e0683b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:友友们 有人投了综述吗 有人知道怎么查目前试验中的临床药物吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff69539530, createdName=ms3000002056268783, createdTime=Wed Jan 08 10:26:15 CST 2025, time=2025-01-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243115, encodeId=03392243115cb, content= 有位审稿人说要提供“full-length images of all Western blot”,各位知道是要整膜的意思吗,本来技术审查已经通过了,是原始的膜,裁膜了,但是上下都有一定距离,带maker。而且我看这个期刊其他已发表文章,放的WB图也有是剪裁的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=mmxgg091801052023, createdTime=Tue Dec 17 15:57:17 CST 2024, time=2024-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240750, encodeId=083b2240e504d, content=偏重的研究方向:肿瘤<br>经验分享:6月底投稿,10.8号返回意见,11月8号返修回去。现在还没有二审回意见。有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Wed Dec 04 09:34:16 CST 2024, time=2024-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2239971, encodeId=715b22399e1c8, content=11月18接收,现在还没online,很多接收的晚的都online了,proof个版面费都交了,有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Nov 29 22:05:47 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239565, encodeId=465f223956533, content=最近,是不是慢了?技术审查5天了,还没结束!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Nov 27 21:06:08 CST 2024, time=2024-11-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582309, encodeId=a934582309f5, content=请问你收到proof了么,我14号接受的还没收到proof<span class="quote">152****5902 2019-12-22 发表::<br>接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span><span class="quote">152****5902 2019-12-22 00:00:00 发表:<br>7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心</span>, beContent=152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51385129903, createdName=14653768m20暂无昵称, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2019-12-29 14653768m20暂无昵称

    请问你收到proof了么,我14号接受的还没收到proof152****5902 2019-12-22 发表::
    接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心
    152****5902 2019-12-22 00:00:00 发表:
    7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心

    152****5902 2019-12-22 发表:: 接收率:约25% 审稿时间:约2个月 7月24号投的,中间寻找审稿人花了很多时间,12月14给一审意见,第一个审稿人建议直接接收,第二个审稿人建议修改标点符号和句首大写后接收,第三个审稿人提了两个问题,花了三个小时修回去了,再送给第三个审稿人,中间两天刚好周末,12月19号审完,12月20号接收,用得来说,编辑很nice,之前投的审稿很快,这次虽然慢点,但是询问信,编辑都耐心的回复,且最后文章接收刚好在毕业之前,很开心

    2

    展开2条回复
共375条页码: 1/38页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分